We identified a novel immuno-oncology target through bacterial metabolites that activate tumor-residing macrophages, triggering a potent anti-tumor response. By leveraging natural metabolic processes, we develop small molecule therapies to enhance the body’s native immune defense against cancer.
- http://www.adularia.ch
- +41 44 632 87 41
- Send an email
- Ana Montalban-Arques
